ASX 50

Market Matters' James Gerrish and Marcus Today's Henry Jennings run the ruler over the best & worst-performing stocks of the past 12 months.

The ASX could be primed for more M&A activity - here are the small cap stocks in the crosshairs

The man who built Pilbara Minerals is running a new ASX lithium hopeful and says soaring demand will help lithium prices recover.

With Telstra’s fiery rally leaving it fully priced, where should investors turn for protection? Bell Potter names two interesting stocks.

Alphinity's Stuart Welch highlights the importance of earnings momentum and shares how his team hunts for companies displaying it.

We review ADNOC’s Santos takeover, market and broker response, the likelihood of a rival bid, and the major hurdles it faces to be approved.

Morgan Stanley’s Chris Nicol says Australia is in a decent spot despite tariffs, slow growth and an expensive stock market.

Valuations are proving anchors without a tip currently, and the current continues to see share prices accelerate.

Israel has attacked Iranian nuclear and missile facilities. How have ASX energy stocks responded and what are the ramifications for the ASX?

Bauxite prices spiked 40% last year, but we think this is just the beginning. Here’s how we’re playing it and why.

Woodside and Santos are rallying on rising Mid-East tensions and crude, but after months of underperforming the ASX 200, can this continue?

Jarden analyst Tom Beadle thinks Xero isn't giving up on the US as this vertiginous growth stock hits new highs.

Two crucial US government bond auctions are due this week. We show you how to read the results and anticipate the impact on your portfolio.

FNArena is a pillar of Australian financial markets news and analysis but it hasn’t all been smooth sailing.

The ASX has a rich vein of quality growth companies, but in some instances, international stocks have better prospects and valuations.

These are the ASX 200 stocks that have been going down but have Strong Buy ratings - are they a bargain or bust?

Valuations are stretched, momentum rules, and quality is being overlooked. Are investors trapped in a fishbowl of euphoria?

Ex-20, not ex-growth: How First Sentier Investors finds Australia’s quiet compounders and holds them for the long run.

Two contrasting strategies, one focus on long-term growth. See how Ben Clark and Adam Dawes think about risk, return, and diversification.

Forget the unicorn hunt. Outperformance lives in evidence-based asymmetry, mispriced assets, and free options the market doesn’t see.

One fund manager warns CBA investors may face the five years of dismal returns that CSL investors have worn.

Schroders' Sebastian Mullins believes the current market volatility means being active is more important than ever

Over the week to 22 May traders increased bets that the shares in these ASX stalwarts are set to fall.

Everyone wants to spot the next growth stock that rises from 50c to $300 in 10 years’ time. Here’s how to give yourself the best chance.